76 related articles for article (PubMed ID: 23928773)
1. Myeloid TGF-β responsiveness promotes metastases.
Souza-Fonseca-Guimaraes F; Smyth MJ
Cancer Discov; 2013 Aug; 3(8):846-8. PubMed ID: 23928773
[TBL] [Abstract][Full Text] [Related]
2. TGF-β signaling in myeloid cells is required for tumor metastasis.
Pang Y; Gara SK; Achyut BR; Li Z; Yan HH; Day CP; Weiss JM; Trinchieri G; Morris JC; Yang L
Cancer Discov; 2013 Aug; 3(8):936-51. PubMed ID: 23661553
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.
Meng X; Vander Ark A; Lee P; Hostetter G; Bhowmick NA; Matrisian LM; Williams BO; Miranti CK; Li X
Oncogene; 2016 May; 35(18):2370-8. PubMed ID: 26279296
[TBL] [Abstract][Full Text] [Related]
4. TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions.
Shaw AK; Pickup MW; Chytil A; Aakre M; Owens P; Moses HL; Novitskiy SV
PLoS One; 2015; 10(1):e0117908. PubMed ID: 25629162
[TBL] [Abstract][Full Text] [Related]
5. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
[TBL] [Abstract][Full Text] [Related]
6. The loss of TGF-beta signaling promotes prostate cancer metastasis.
Tu WH; Thomas TZ; Masumori N; Bhowmick NA; Gorska AE; Shyr Y; Kasper S; Case T; Roberts RL; Shappell SB; Moses HL; Matusik RJ
Neoplasia; 2003; 5(3):267-77. PubMed ID: 12869309
[TBL] [Abstract][Full Text] [Related]
7. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
8. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
9. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
Yamamura S; Matsumura N; Mandai M; Huang Z; Oura T; Baba T; Hamanishi J; Yamaguchi K; Kang HS; Okamoto T; Abiko K; Mori S; Murphy SK; Konishi I
Int J Cancer; 2012 Jan; 130(1):20-8. PubMed ID: 21503873
[TBL] [Abstract][Full Text] [Related]
10. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
Feng XH; Derynck R
EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801
[TBL] [Abstract][Full Text] [Related]
11. Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling.
Ungefroren H; Witte D; Rauch BH; Settmacher U; Lehnert H; Gieseler F; Kaufmann R
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165389
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer.
Buczek ME; Miles AK; Green W; Johnson C; Boocock DJ; Pockley AG; Rees RC; Hulman G; van Schalkwyk G; Parkinson R; Hulman J; Powe DG; Regad T
Oncogene; 2016 Jun; 35(26):3465-75. PubMed ID: 26549027
[TBL] [Abstract][Full Text] [Related]
13. Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.
Zeeh F; Witte D; Gädeken T; Rauch BH; Grage-Griebenow E; Leinung N; Fromm SJ; Stölting S; Mihara K; Kaufmann R; Settmacher U; Lehnert H; Hollenberg MD; Ungefroren H
Oncotarget; 2016 Jul; 7(27):41095-41109. PubMed ID: 27248167
[TBL] [Abstract][Full Text] [Related]
14. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
[TBL] [Abstract][Full Text] [Related]
15. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
Yang L; Huang J; Ren X; Gorska AE; Chytil A; Aakre M; Carbone DP; Matrisian LM; Richmond A; Lin PC; Moses HL
Cancer Cell; 2008 Jan; 13(1):23-35. PubMed ID: 18167337
[TBL] [Abstract][Full Text] [Related]
17. Exploring anti-TGF-β therapies in cancer and fibrosis.
Hawinkels LJ; Ten Dijke P
Growth Factors; 2011 Aug; 29(4):140-52. PubMed ID: 21718111
[TBL] [Abstract][Full Text] [Related]
18. Transforming Growth Factor-β Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses.
Konkel JE; Zhang D; Zanvit P; Chia C; Zangarle-Murray T; Jin W; Wang S; Chen W
Immunity; 2017 Apr; 46(4):660-674. PubMed ID: 28423340
[TBL] [Abstract][Full Text] [Related]
19. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
